Benjamin Cryer

Jan 27, 2025 | biorxiv.org | Brian Thomas |Xue Bai |Benjamin Cryer |Sydney M Escobar

AbstractThe discovery of immune checkpoints and the rapid growth of immuno-oncology (IO) have sparked tremendous efforts to utilize the immune system to treat a wide range of cancer types/subtypes. While the major focus of IO over the past decades has been to manipulate the adaptive immune system, recent attention has been given to manipulating the innate immune system to treat cancer and/or to enhance adaptive responses.